Predictive factors for improvement of international prostatic symptom score for patients following Transurethral resection of prostate

Shabarinath. B; Ramreddy C.H; Rahul Devraj; Vidyasagar.S; Ramchandraiah; Raghuveer; Charan Kumar; Kiran; Jitender

Volume : VIII, Issue : II, February - 2019

Predictive factors for improvement of international prostatic symptom score for patients following Transurethral resection of prostate

Shabarinath. B, Ramreddy C. H, Rahul Devraj, Vidyasagar. S, Ramchandraiah, Raghuveer, Charan Kumar, Kiran, Jitender

Abstract :

Introduction : Prostate is one of the major accessory sex gland of male reproductive system. Benign prostatic hyperplasia (BPH) is one of the most common problems of aging males all over the world. Benign prostatic hyperplasia produces variety of lower urinary tract symptoms (LUTS) which can lead to simple disturbances in work to severe restriction of day today activities leading to poor quality of life. International prostatic symptom score (IPSS) is widely used as a tool to quantify symptoms related to benign prostatic enlargement. IPSS is the available best tool to grade the symptom severity, assessment of responsiveness to therapy and used to detect the symptom progression in patients with BPH. Materials and Methods : Single institute study of predictive factors for improvement of IPSS score following bipolar TURP over a period of 2 years is done. All patients undergoing TURP preoperative factors like Age, Size of the gland, History of Acute urinary symptom episode, Predominantly obstructive symptoms, Failed medical therapy, Presence of significant post void residue, presence of Median lobe, Resection time were considered and their pre and post operative IPSS score is considered. Results : 80 patients were included in the study. The above mentioned factors were studied and their pre and post operative IPSS score is compared showing significant improvement in IPSS score when gland size, predominantly obstructive symptoms, episode of AUR, failed medical treatment and presence of median lobe are considered. Conclusion : IPSS can be used to assess the symptomatic response to therapy. The factors like gland size, predominantly obstructive symptoms, episode of AUR, failed medical treatment and presence of median lobe can predict the improvement in IPSS following TURP in patients with BPH.